Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine vs Sildenafil in Thalassemia-associated Pulmonary Hypertension
NCT03402191Phase 4Unknown
- Start
- Jul 2016
- Primary completion
- Dec 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of arginine in pulmonary hypertension (PH) (3 arms). Primary endpoint: Number of patients with improvement of pulmonary hypertension at 6 months. Status: unknown.
02
Drugs
arginine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03402191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402191.